who shouldn't take tirzepatide Should Avoid Tirzepatide? Safety Guidelines in Diabetes Treatment What Happens When You Switch

Lorenzo Leggio and Dr

Wegovy (semaglutide) is an injectable prescription medicine to help with patients lose weight and keep it off

The article says tirzepatide's dual GIP and GLP-1 mechanism engages additional metabolic and appetite-regulating circuits, and may influence glucose metabolism and gastric motility in ways that differ from GLP-1 activation alone

Additionally, cannabis may interact with the bodys endocannabinoid system, which is involved in regulating energy storage and expenditure

Polymorphisms in the GLP1R gene, particularly the rs6923761 variant, can reduce your response to pure GLP-1 agonists like semaglutide